San Francisco, California
London, United Kingdom
The future of Parkinson’s
From prediction to prevention
The early stages of Parkinson’s are very hard to identify – movement features of the condition only appear once half the dopamine-producing nerve cells in the brain have already been lost. The nerve cells start dying many years before symptoms appear.
Researchers are on the hunt for new and better treatments that can stop the loss of dopamine-producing nerve cells and encourage damaged cells to grow back. But they are aware these treatments will probably be most effective if there are more nerve cells to save.
To find and develop new treatments, it will be important to test them in the early stages of Parkinson’s. This does not mean that this type of treatments will only benefit people in the early stages of Parkinson’s. Only that the more effective a treatment is, the easier it will pass through clinical trials which are needed for a new treatment to be made available.
If we could identify people in the earliest stages of Parkinson’s – before they are diagnosed or even develop symptoms – we would be in the best possible position to slow, stop or even reverse Parkinson’s for everyone with the condition.
The lecture will begin with Dr Alastair Noyce, University College London, who will discuss the results of his study Predicting Parkinson’s. For the study, Alastair successfully recruited over 1000 people without Parkinson’s aged 60-80 to complete an in-depth online questionnaire about their health, a ‘keyboard tap test’ to measure accuracy and speed of movement and a ‘scratch and sniff’ style smell test.
Following Alastair we will hear from Peter Jenner, Emeritus Professor at Kings College London. Peter will give an overview of the progress towards treatments that stop Parkinson’s in its tracks. He will also highlight Parkinson’s UK’s role in focusing on better treatments and a cure through the implementation of our virtual biotech.
This event brings together two areas of research that are key to unlocking better treatments for Parkinson’s and invites you to imagine a future where we have a cure. Because, if we can predict those who will develop symptoms and treat them early with drugs that stop the loss of nerve cells, we can prevent Parkinson’s.
When & Where
We're the Parkinson's support and research charity. For more than 40 years we've been working to find a cure and improve life for everyone affected by Parkinson's.